Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BIOAL, formally Biotecnologia de Alimentos, is a Peru-based biotechnology services company focused on biomolecular analysis for the food, agro-industrial, fisheries, aquaculture, environmental, and related health sectors. The company operates laboratory services based on DNA-, protein-, microbiology-, and biochemistry-based testing, with capabilities that include genetically modified organism detection, pathogenic bacteria detection, DNA barcoding, metabarcoding, and environmental DNA analysis. BIOAL appears to be primarily a testing and applied biotechnology services business rather than a therapeutic drug developer, so it does not have a conventional clinical pipeline. Its business is centered on commercial laboratory services and customized analytical support for product quality, traceability, and biosurveillance applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BIOAL.